Clinical Trial Update: SUMMIT Now Enrolling Mitral Valve Patients!

The new SUMMIT Clinical Trial will evaluate the Tendyne™ Mitral Valve System that replaces the patient’s defective mitral valve without an incision to the patient’s sternum. The Tendyne™ therapy is a minimally-invasive alternative to open-heart surgery that does not require the patient to be on the heart-lung machine. Watch this educational video to learn about the SUMMIT Clinical Trial that will evaluate the Tendyne™ Mitral Valve System. (Video posted on June 2, 2021)